- Error
Antiretroviral PrEP Prevents HIV Transmission among Injection Drug Users
Pre-exposure prophylaxis (PrEP) using daily oral tenofovir (Viread) reduced the risk of HIV acquisition among injection drug users in Thailand by half, according to findings from the Bangkok Tenofovir Study, published in the June 13, 2013, advance online edition of The Lancet . These findings led the CDC to recommend that PrEP be "considered as one of several prevention options for persons at very high risk for HIV acquisition" through injection drug use.
![CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]](/images/resized/images/conf-photos/CROI2013/persaud-interview-img_3293-rect-500_330_228.jpg)
HIV/AIDS
GRACE Survey Sheds Light on Treatment Benefits and Barriers for HIV+ Women
Caring for children, unemployment, and transportation difficulties were among th...
Some Men Shed HIV in Semen Despite ART, Linked to Herpesvirus Coinfection
About 10% of gay men in a U.S. study had detectable HIV in their semen despite s...
U.S. Preventive Services Task Force Recommends Routine HIV Screening for Adolescents and Adults
On April 30 the U.S. Preventive Services Task Force (USPSTF) issued a "Grad...
Lack of Food Linked to More Hospitalizations among HIV+ People with Unstable Housing
Homeless and marginally housed people with HIV in San Francisco who experienced ...
Hepatitis B
DDW 2003: Tenofovir and Entecavir Effectively Suppress Hepatitis B Virus
The newer antivirals tenofovir (Viread) and entecavir (Baraclude) inhibit hepati...
FDA Rejects Heplisav Hepatitis B Vaccine Seeking More Safety Data
The U.S. Food and Drug Administration (FDA) has declined to approve Dynavax...
National Hepatitis Testing Day: Most Infected Are Unaware, All Boomers Should Get HCV Test
In advance of the National Hepatitis Testing Day on Saturday, May 19, the U.S. C...
Everolimus (Zortress) Approved to Prevent Liver Transplant Rejection
The U.S. Food and Drug Administration (FDA) this month approved the immunos...
Hepatitis C
DDW 2013: Prior Non-responders Can Achieve Good SVR Rates with Boceprevir Triple Therapy
People previously treated with interferon-based therapy can achieve good results...
War on Drugs Is Major Driver of Global Hepatitis C Epidemic
The so-called "war on drugs" plays a major role is sustaining hepatiti...
Sunday is Hepatitis Testing Day -- All Baby Boomers Should Get Hep C Test
May 19 is the second annual Viral Hepatitis Testing Day, an opportunity to raise...
EASL 2013: HIV/HCV Coinfected Patients More Likely to Develop Cirrhosis, but Treatment Lowers Risk
Sustained response to hepatitis C treatment leads to slow regression of liver fi...
HIV/Hepatitis Coinfection
Tenofovir plus Emtricitabine or Lamivudine Does Not Always Suppress Hepatitis B in HIV/HBV Coinfected
HIV/HBV coinfected people with high hepatitis B virus (HBV) levels and those who...
EASL 2013: HIV/HCV Coinfected at Risk for Decompensation, May Need Prompt Treatment
HIV positive people with hepatitis C coinfection may experience liver&...
Adefovir plus Hepatitis C Therapy May Prevent HBV Reactivation in HBV-HCV Coinfected Patients
Due to the similar transmission routes, many people are dually infected with bot...
Other Health News
Vitamin C Rapidly Kills Drug-resistant Tuberculosis Bacteria
Vitamin C causes a chemical reaction that rapidly destroys Mycobacterium &nb...
Does Human Papillomavirus Contribute to Lung Cancer?
A small proportion of lung cancers may be caused by the same high-risk strains o...
Drug-resistant Gonorrhea Makes its Way into North America
The first documented failure of oral treatment for gonorrhea in North America ha...
2012-2013 Could Be Bad Flu Season, Not Too Late to Get Vaccine, CDC Advises
Significant increases in influenza activity in the U.S. during the past 2 weeks ...
Subscribe To Our Newsletter
Sign up for our free twice-weekly e-newsletter
CONTINUING MEDICAL EDUCATION
CONFERENCE COVERAGE
48th International Liver Congress (EASL 2013)
April 24-28, 2013, Amsterdam
|
Digestive Disease Week |
|
|
20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) |
|
 |
The Liver Meeting (AASLD 2012) |
 |
11th International Congress on Drug Therapy in HIV Infection (HIV11) |
 |
52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) |
 |
XIX International AIDS Conference (AIDS 2012) |
Copyright © 2013 hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com.
Joomla! is Free Software released under the GNU General Public License.
Web Design and Development by Bread and Roses Web Design